What to Limit Sugary and ultra-processed foods Diets high in added sugars and refined carbs are linked to reduced post-meal GLP-1 responses and poorer glucose control, especially in individuals with obesity
Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: A randomised, double-blind, placebo-controlled trial
At Klinic, we connect you with knowledgeable healthcare providers who will evaluate if a Zepbound prescription is right for you
Coulter says people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should not take them
On April 30, 2026, the FDA further proposed formally excluding both from the 503B Bulks List - a proposal that, if finalized after the June 29, 2026 comment period, would close the remaining large-scale outsourcing facility pathway